|
Pronunciation |
|
(hye
droe KOE done & a seet a MIN
oh fen) |

|
|
U.S. Brand
Names |
|
Anexsia®; Anodynos-DHC®; Bancap
HC®; Co-Gesic®; Dolacet®; DuoCet™;
Hydrocet®; Hydrogesic®; Hy-Phen®; Lorcet®;
Lorcet®-HD; Lorcet® Plus; Lortab®; Margesic®
H; Medipain 5®; Norco®; Stagesic®; T-Gesic®;
Vicodin®; Vicodin® ES; Vicodin® HP;
Zydone® |

|
|
Generic
Available |
|
Yes |

|
|
Canadian Brand
Names |
|
Vapocet® |

|
|
Synonyms |
|
Acetaminophen and Hydrocodone |

|
|
Pharmacological Index |
|
Analgesic, Narcotic |

|
|
Use |
|
Dental: Treatment of postoperative pain
Medical: Relief of moderate to severe pain; antitussive (hydrocodone)
|

|
|
Restrictions |
|
C-III |

|
|
Pregnancy Risk
Factor |
|
C |

|
|
Contraindications |
|
CNS depression, hypersensitivity to hydrocodone, acetaminophen or any
component; severe respiratory depression |

|
|
Warnings/Precautions |
|
Use with caution in patients with hypersensitivity reactions to other
phenanthrene derivative opioid agonists (morphine, hydrocodone, hydromorphone,
levorphanol, oxycodone, oxymorphone); tablets contain metabisulfite which may
cause allergic reactions; tolerance or drug dependence may result from extended
use |

|
|
Adverse
Reactions |
|
>10%:
Cardiovascular: Hypotension
Central nervous system: Lightheadedness, dizziness, sedation, drowsiness,
fatigue
Neuromuscular & skeletal: Weakness
1% to 10%:
Cardiovascular: Bradycardia
Central nervous system: Confusion
Gastrointestinal: Nausea, vomiting
Genitourinary: Decreased urination
Respiratory: Shortness of breath, dyspnea
<1%: Hypertension, hallucinations, xerostomia, anorexia, biliary tract
spasm, urinary tract spasm, diplopia, miosis, histamine release, physical and
psychological dependence with prolonged use |

|
|
Overdosage/Toxicology |
|
Symptoms of overdose include hepatic necrosis, blood dyscrasias, respiratory
depression
Acetylcysteine 140 mg/kg orally (loading) followed by 70 mg/kg every 4 hours
for 17 doses. Therapy should be initiated based upon laboratory analysis
suggesting high probability of hepatotoxic potential. Naloxone (2 mg I.V.) can
also be used to reverse the toxic effects of the opiate. Activated charcoal is
effective at binding certain chemicals, and this is especially true for
acetaminophen. |

|
|
Drug
Interactions |
|
Decreased effect with phenothiazines
Increased effect with dextroamphetamine
Increased toxicity with CNS depressants, TCAs; effect of warfarin may be
enhanced |

|
|
Mechanism of
Action |
|
See individual agents |

|
|
Pharmacodynamics/Kinetics |
|
Onset of narcotic analgesia: Within 10-20 minutes
Duration: 3-6 hours
Distribution: Crosses the placenta
Metabolism: In the liver
Half-life: 3.8 hours
Elimination: In urine |

|
|
Usual Dosage |
|
Oral (doses should be titrated to appropriate analgesic effect):
Antitussive (hydrocodone): 0.6 mg/kg/day in 3-4 divided doses
A single dose should not exceed 10 mg in children >12 years, 5 mg in
children 2-12 years, and 1.25 mg in children <2 years of age
Analgesic (acetaminophen): Refer to Acetaminophen monograph
Adults: Analgesic: 1-2 tablets or capsules every 4-6 hours or 5-10 mL
solution every 4-6 hours as needed for pain |

|
|
Dietary
Considerations |
|
No data reported |

|
|
Monitoring
Parameters |
|
Pain relief, respiratory and mental status, blood
pressure |

|
|
Mental Health: Effects
on Mental Status |
|
Sedation is common; may cause confusion; may rarely cause
hallucinations |

|
|
Mental Health:
Effects on Psychiatric
Treatment |
|
May result in loss of pain control when used in combination with SSRIs
(especially paroxetine and fluoxetine); concurrent use with psychotropics may
produce additive sedation |

|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |

|
|
Dental Health:
Effects on Dental Treatment |
|
<1% of patients experience dry mouth |

|
|
Patient
Information |
|
If self-administered, use exactly as directed (do not increase dose or
frequency); may cause physical and/or psychological dependence. Take with food
or milk. While using this medication, do not use alcohol and other prescription
or OTC medications (especially sedatives, tranquilizers, antihistamines, or pain
medications) without consulting prescriber. Maintain adequate hydration (2-3
L/day of fluids unless instructed to restrict fluid intake). May cause
dizziness, lightheadedness, confusion, or drowsiness (use caution when driving,
climbing stairs, or changing position - rising from sitting or lying to
standing, or when engaging in tasks requiring alertness until response to drug
is known); nausea or vomiting (frequent mouth care, frequent sips of fluids,
chewing gum, or sucking lozenges may help). Report chest pain or palpitations;
persistent dizziness, shortness of breath, or difficulty breathing; unusual
bleeding or bruising; or unusual fatigue and weakness.
Pregnancy/breast-feeding precautions: Inform prescriber if you are or intend
to be pregnant. Do not breast-feed. |

|
|
Nursing
Implications |
|
Observe patient for excessive sedation, respiratory
depression |

|
|
Dosage Forms |
|
Capsule:
Bancap HC®, Dolacet®,
Hydrocet®, Hydrogesic®,
Lorcet®-HD, Margesic® H, Medipain
5®, Norcet®,
Stagesic®, T-Gesic®,
Zydone®: Hydrocodone bitartrate 5 mg and acetaminophen 500
mg
Elixir (tropical fruit punch flavor) (Lortab®):
Hydrocodone bitartrate 2.5 mg and acetaminophen 167 mg per 5 mL with alcohol 7%
(480 mL)
Solution, oral (tropical fruit punch flavor) (Lortab®):
Hydrocodone bitartrate 2.5 mg and acetaminophen 167 mg per 5 mL with alcohol 7%
(480 mL)
Tablet: Hydrocodone bitartrate 5 mg and acetaminophen 400 mg; hydrocodone
bitartrate 7.5 mg and acetaminophen 400 mg; hydrocodone bitartrate 10 mg and
acetaminophen 400 mg; hydrocodone bitartrate 5 mg and acetaminophen 500 mg;
hydrocodone bitartrate 7.5 mg and acetaminophen 750 mg; hydrocodone bitartrate
7.5 mg and acetaminophen 500 mg; hydrocodone bitartrate 7.5 mg and acetaminophen
650 mg; hydrocodone bitartrate 10 mg and acetaminophen 650 mg
Lortab® 2.5/500: Hydrocodone bitartrate 2.5 mg and
acetaminophen 500 mg
Anexsia® 5/500, Anodynos-DHC®,
Co-Gesic®, DuoCet™,
DHC®; Hy-Phen®,
Lorcet®,
Lortab®® 5/500,
Vicodin®: Hydrocodone bitartrate 5 mg and acetaminophen
500 mg
Lortab® 7.5/500: Hydrocodone bitartrate 7.5 mg and
acetaminophen 500 mg
Anexsia® 7.5/650, Lorcet® Plus:
Hydrocodone bitartrate 7.5 mg and acetaminophen 650 mg
Vicodin® ES: Hydrocodone bitartrate 7.5 mg and
acetaminophen 750 mg
Norco®: Hydrocodone bitartrate 10 mg and acetaminophen
325 mg
Lortab® 10/500: Hydrocodone bitartrate 10 mg and
acetaminophen 500 mg
Lorcet® 10/650: Hydrocodone bitartrate 10 mg and
acetaminophen 650 mg
Vicodin® HP: Hydrocodone bitartrate 10 mg and
acetaminophen 660 mg
Zydone®: Hydrocodone bitartrate 5 mg and acetaminophen
400 mg; hydrocodone bitartrate 7.5 mg and acetaminophen 400 mg; Hydrocodone
bitartrate 10 mg and acetaminophen 400 mg |

|
|
References |
|
Dionne RA, "New Approaches to Preventing and Treating Postoperative Pain,"
J Am Dent Assoc, 1992, 123(6):26-34.
Gobetti JP, "Controlling Dental Pain," J Am Dent Assoc, 1992,
123(6):47-52. |

|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|